Alcatel-Lucent Plans New Cost-Cuts
Alcatel-Lucent SA (ALU.FR) Thursday said it plans 750 million euros ($908 million) in new cost-cuts by the end of 2013, including the elimination of 5,000 jobs, after the telecommunications-equipment maker swung to a loss in the second quarter amid cutthroat competition and a sluggish economic
Siemens Warns On Full Year Guidance
German industrial conglomerate Siemens AG (SI) on Thursday published a fiscal third-quarter order intake sharply below analysts' estimates and said it is becoming more difficult to achieve its full-year profit guidance.
Roche 1st Half Net Drops; Confirms Outlook
Roche Holding AG (ROG.VX) Thursday reported a drop in first-half profit, mainly due to the closure of a U.S. site even as sales rose on a strong performance from its cancer drugs, and confirmed its full-year guidance.
Formosa to Shut No. 2 Naphtha Cracker Aug 15 for 1 Month
Taiwan's Formosa Petrochemical Corp. (6505.TW), Asia's top naphtha buyer, will shut down its No.
ABB CEO Sees Encouraging Signs For Company In China
Industrial robot and power line builder ABB Ltd. (ABBN.VX) sees some signs of recovery in its China business, Chief Executive Joe Hogan said Thursday.
BASF 2Q Sales Beat Expectations; Net Profit Down on Year
BASF SE (BAS.XE), the world's largest chemicals company by sales, on Thursday confirmed its full-year outlook, despite a slump in net profit, after beating analysts' expectations for sales and earnings before interest and taxes in the second quarter due to a strong performance in its Agricultural
PKN Orlen Swings to Net Loss of PLN5.2 Million
Polish state-controlled refiner PKN Orlen SA (PKN.WA) swung to a PLN5.2 million zloty ($1.51 million) second-quarter loss Thursday compared with a net profit of PLN899 million a year ago as a downward revaluation of its oil reserves offset a period of fat margins.
Sanofi Second-Quarter Net Profit up 16% Boosted by Tax Effect
France's top drug maker Sanofi SA (SNY, SAN.FR) said Thursday it expected its earnings to fall this year, dented by the loss of patents on some of its blockbuster drugs, even as it posted a firm increase in second-quarter net profit, boosted by a tax effect.
Roche Gets FDA Clearance For Vitamin D Laboratory Test
Roche Holding AG (ROG.VX) Thursday said it received clearance from the U.S. Food and Drug Administration for a fully automated vitamin D test for use on cobas modular platforms, further expanding the company's bone metabolism test menu.
Carlyle-Backed Coates Hire IPO to Raise Up to A$700 Million -Sources
Private equity firm Carlyle Group (CG) and Australia's Seven Group Holdings (SVW.AU) are seeking to raise up to A$700 million through an initial public offering of equipment-hire group Coates Hire, two people familiar with the matter said Thursday.